Large-Scale Trial of Vaginal Ring That Releases Anti-HIV Drug Announced at Health Summit in London
June 15, 2012
"This week, at the Pacific Health Summit in London, the final large-scale trial was officially launched of a vaginal ring which women can wear and forget about -- at least for a month at a time -- while it releases an HIV virus-killing drug called dapivirine," the Guardian reports. "If successful, it could also be combined with hormonal contraception," the newspaper notes. The phase III clinical trial, "launched by the International Partnership for Microbicides, is already recruiting women in South Africa, Rwanda and Malawi" and "will involve 1,650 women -- enough to prove definitively whether it works," according to the newspaper (Boseley, 6/13).
This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.
Less Expensive ARV Combination Just as Effective for Women in Developing Countries as Costlier ARVs, Study Shows
No comments have been made.
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)